Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: Stimulation by YC-1, nitric oxide, and carbon monoxide

Journal of Molecular Medicine

Volumn 77, Issue 1, 1999, Pages 14-23

  Hoenicka, Markus ^a   Becker, Eva Maria ^b   Apeler, Heiner ^b   Sirichoke, Tim ^b   Schröder, Henning ^c   Gerzer, Rupert ^a   Stasch, Johannes Peter ^b  

^a GERMAN AEROSPACE CENTER DLR   (Germany)

^b BAYER AG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Guanylate cyclase (isolation and purification), YC 1, Nitric oxide (pharmacology), Heme (physiology), Recombinant proteins (biosynthesis)

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; CARBON MONOXIDE; GUANYLATE CYCLASE; HEME; NITRIC OXIDE; RECOMBINANT PROTEIN;

ARTICLE; BACULOVIRUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME PURIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; NONHUMAN; PROTEIN EXPRESSION;

EID: 0033016797     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050292     Document Type: Article

References (46)

1. 1. Bredt DS, Snyder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175-195
2. 2. Koesling D, Böhme E, Schultz G (1991) Guanylyl cyclases, a growing family of signal-transducing enzymes. FASEB J 5:2785-2791
3. 3. Arnold WP, Mittal CK, Katsuki S, Murad F (1977) Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 74:3203-3207
4. 4. Ko F-N, Wu C-C, Kuo S-C, Lee F-Y, Teng C-M (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84: 4226-4233
5. 5. Brüne B, Schmidt K-U, Ullrich V (1990) Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 192:683-688
6. 6. Glass DB, Frey W, Carr DW, Goldberg ND (1977) Stimulation of human platelet guanylate cyclase by fatty acids. J Biol Chem 252:1279-1285
7. 7. Gerzer R, Hofmann F, Schultz G (1981) Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. Eur J Biochem 116:479-486
8. 8. Gerzer R, Böhme E, Hofmann F, Schultz G (1981) Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 132:71-74
9. 9. Kamisaki Y, Saheki S, Nakane M, Palmieri JA, Kuno T, Chang BY, Waldmann SA, Murad F (1986) Soluble guanylate cyclase from rat lung exists as a heterodimer. J Biol Chem 261: 7236-7241
10. 10. Nakane M, Arai K, Saheki S, Kuno T, Buechler WA, Murad F (1990) Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 265:16841-16845
11. 11. Hobbs AJ (1997) Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol Sci 18:484-491
12. 12. Wu C-C, Ko F-N, Kuo S-C, Lee F-Y, Teng C-M (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 116:1973-1978
13. 13. Friebe A, Schultz G, Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15:6863-6868
14. 14. Mülsch A, Bauersachs J, Schafer A, Stasch JP, Kast R, Busse R (1997) Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol 120:681-689
15. 15. Mülsch A, Bauersachs J, Stasch JP, Busse R (1997) Potentiation of vascular responses to NO-donors by an NO-independent activator of soluble guanylyl cyclase. Naunyn-Schmiedebergs Arch Pharmacol 355(4):R47 (abstract)
16. 16. Teng CM, Wu CC, Ko FN, Lee FY, Kuo SC (1997) YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Eur J Pharmacol 320:161-166
17. 17. Wu CC, Ko FN, Teng CM (1997) Inhibition of platelet adhesion to collagen by cGMP-elevating agents. Biochem Biophys Res Commun 231:412-416
18. 18. Yu SM, Cheng ZJ, Guh JH, Lee FY, Kuo SC (1995) Mechanism of anti-proliferation caused by YC-1, an indazole derivate, in cultured rat A10 vascular smooth-muscle cells. Biochem J 306:787-792
19. 19. Stone JR, Marletta MA (1994) Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33:5636-5640
20. 20. Buechler WA, Singh S, Aktas J, Müller S, Murad F, Gerzer R (1995) High-level expression of biologically active soluble guanylate cyclase using the baculovirus system is strongly heme-dependent. In: Ignarro L, Murad F (eds) Nitric oxide - biochemistry, molecular biology, and therapeutic implications. Academic Press, San Diego, pp 293-303
21. 21. Smith KM (1975) Porphyrins and metalloporphyrins. Elsevier, Amsterdam
22. 22. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
23. 23. Groves WE, Davis FC Jr, Sells BH (1968) Spectrophotometric determination of microgram quantities of protein without nucleic acid interference. Anal Biochem 22:195-210
24. 24. Yoshina S, Kuo SC (1978) Studies on heterocyclic compounds. XXXV. Synthesis of furo[3,2-C]pyrazole derivatives (2) Electrophilic substitution of 1,3-diphenylfuro[3,2-C]pyrazole. Yakugaku Zasshi 98:204
25. 25. Gupta G, Kim J, Yang L, Sturley SL, Danziger RS (1997) Expression and purification of soluble, active heterodimeric guanylyl cyclase from baculovirus. Protein Expr Purif 10:325-330
26. 26. Gerzer R, Radany EW, Garbers DL (1982) The separation of the heme and apoheme forms of soluble guanylate cyclase. Biochem Biophys Res Commun 108:678-686
27. 27. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48:184-188
28. 28. Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A (1998) Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br J Pharmacol 123:299-309
29. 29. Buechler WA, Nakane M, Murad F (1991) Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem Biophys Res Commun 174:351-357
30. 30. Harteneck C, Koesling D, Soeling A, Schultz G, Böhme E (1990) Expression of soluble guanylyl cyclase - catalytic activity requires two enzyme subunits. FEBS Lett 272:221-223
31. 31. Kioukia N, Nienow AW, Emery AN, Al-Rubeai M (1995) Physiological and environmental factors affecting the growth of insect cells and infection with baculovirus. J Biotechnol 38:243-251
32. 32. List BM, Klatt P, Werner ER, Schmidt K, Mayer B (1996) Overexpression of neuronal nitric oxide synthase in insect cells reveals requirement of haem for tetrahydrobiopterin binding. Biochem J 315:57-63
33. 33. Wedel B, Humbert P, Harteneck C, Foerster J, Malkewitz J, Böhme E, Schultz G, Koesling D (1994) Mutation of His-105 in the beta1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci USA 91:2592-2596
34. 34. Stone JR, Marletta MA (1995) Heme stoichiometry of heterodimeric soluble guanylate cyclase. Biochemistry 34: 14668-14674
35. 35. Zhao Y, Marletta MA (1997) Localization of the heme binding region in soluble guanylate cyclase. Biochemistry 36: 15959-15964
36. 36. Zhao Y, Schelvis JP, Babcock GT, Marletta MA (1998) Identification of histidine 105 in the beta1 subunit of soluble guanylate cyclase as the heme proximal ligand. Biochemistry 37: 4502-4509
37. 37. Fan B, Gupta G, Danziger RS, Friedman JM, Rousseau DL (1998) Resonance Raman characterization of soluble guanylate cyclase expressed from baculovirus. Biochemistry 37: 1178-1184
38. 1 subunits. Eur J Biochem 240:380-386
39. 39. Schrammel A, Behrends S, Schmidt K, Koesling D, Mayer B (1996) Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50:1-5
40. 40. Ignarro LJ, Wood KS, Wolin MS (1982) Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proc Natl Acad Sci U S A 79:2870-2873
41. 41. Ramarao CS, Garbers DL (1988) Purification and properties of the phosphorylated form of guanylate cyclase. J Biol Chem 263:1524-1529
42. 42. Friebe A, Koesling D (1998) Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol 53:123-127
43. 43. Wu XB, Brune B, von Appen F, Ullrich V (1992) Reversible activation of soluble guanylate cyclase by oxidizing agents. Arch Biochem Biophys 294:75-82
44. 44. Braughler JM (1980) Oxidative modulation of soluble guanylate cyclase by manganese. Biochim Biophys Acta 616:94-104
45. 45. Mittal CK, Murad F (1977) Properties and oxidative regulation of guanylate cyclase. J Cyclic Nucleotide Res 3:381-391
46. 46. Friebe A, Malkewitz J, Schultz G, Koesling D (1996) Positive effects of pollution? Nature 382:120